Joint presidents to run Wolters Kluwer analytics biz

Share this article:
Wolters Kluwer Pharma Solutions jointly appointed Bob Jansen and Michelle Woker as co-presidents of its analytics business.

Jansen and Woker will lead the commercial and operations functions, respectively. Their promotions follow the retirement of former Wolters Kluwer Pharma Solutions head Mark Spiers in April. Bob Becker, head of parent company Wolters Kluwer Health & Pharma Solutions, has been running the unit in the interim. The new leaders will report directly to him.

Jansen has been SVP, commercial operations, for Wolters Kluwer Pharma Solutions' healthcare analytics business since 2007. Prior to that, he had helped lead managed markets sales and contracting areas for a number of pharmaceutical companies. Woker has been with the healthcare analytics business for 17 years, most recently as SVP, operations.

Jansen and Woker are responsible for healthcare analytics only. The publishing side of the company is run by different leadership in place since prior to Spiers' departure. Wolters Kluwer Pharma Solutions is a unit of Wolters Kluwer Health & Pharma Solutions, a division of Wolters Kluwer.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in News

Five things for Pharma Marketers to know: Friday, August 29

Five things for Pharma Marketers to know: Friday, ...

Takeda closes out a good-news, bad-news kind of week, AstraZeneca adds a new clinical trial for its experimental PD-1, and researchers link a funeral to the Ebola outbreak.

Amgen sends PCSK9 to FDA

Amgen sends PCSK9 to FDA

Evolocumab holds the FDA's first filed biologics license application for the class.

Consultants expect M&A tempo to continue

Consultants expect M&A tempo to continue

PwC anticipates that divestitures will fuel late-2014 deals, but notes that the noise around early deals and the financials don't fully match up.